✦ LIBER ✦

Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores

✍ Scribed by C. U. Niemann; M. Behrends; D. Quan; H. Eilers; M. A. Gropper; J. P. Roberts; R. Hirose

Book ID: 110868857
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 125 KB
Volume: 16
Category: Article
ISSN: 0958-7578
DOI: 10.1111/j.1365-3148.2006.00653.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preoperative characteristics and intraop

Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores

✍ Victor W. Xia; Bin Du; Michelle Braunfeld; Gundappa Neelakanta; Ke-Qin Hu; Hamid 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Recent changes in organ allocation based on the model for end-stage liver disease (MELD) prioritize the most ill patients on the waiting list for liver transplantation. While patients undergoing liver transplantation in the MELD era are more acutely ill, the impact of the policy changes on periopera

Recombinant factor VIIa improves clot fo

Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation

✍ Ton Lisman; Frank W.G. Leebeek; Karina Meijer; Jan Van Der Meer; H.Karel Nieuwen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

Liver transplantation in a patient with

Liver transplantation in a patient with mild haemophilia A and low-titres of factor VIII inhibitors treated with recombinant factor VIIa. The first Argentinean case

✍ H. GUGLIELMONE; G. JARCHUM; S. MINOLDO 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

7 Adefovir dipivoxil (ADV) provides sign

7 Adefovir dipivoxil (ADV) provides significant clinical benefit, reduces meld score and prevents transplantation in chronic hepatitis B patients wait-listed for liver transplantation (OLT) with lamivudine-resistance (LAM-R)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Recombinant factor VIIA improves clot fo

Recombinant factor VIIA improves clot formation but not TAFI-mediated downregulation of fibrinolysis in patients with cirrhosis and during liver transplantation: Ton Lisman, University Medical Centre Utrecht, Utrecht Netherlands; Frank W Leebeek, University Hospital Dijkzigt, Rotterdam Netherlands; Karina Meijer, Jan Van der Meer, University Hospital Groningen, Groningen Netherlands; H K Nieuwenhuis, Philip G De Groot, University Medical Centre Utrecht, Utrecht Netherlands

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB